It’s a narrow win for the athletes, but it could foreshadow a much bigger victory.
Why HR 1, known as the For the People Act, is intricately linked with Biden’s foreign policy.
You may not be the only one controlling your smart thermostat.
Why the Southern Baptist Convention is in turmoil — and why you should care.
There’s a crop of influencers romanticizing the workday. Is that a good thing?
Don’t worry if you haven’t grown as a person during the pandemic.
US Catholic leadership is divided on how to approach pro-choice Catholic politicians.
A neuroscientist’s studies show that altruism isn’t always attractive.
A $55,000 drug that doesn’t cure Alzheimer’s
After 20 years of waiting, there’s a new drug to treat Alzheimer’s. For some patients, it’s a glimmer of hope. For some scientists, it’s one of the FDA’s worst drug approval decisions ever.